PHILADELPHIA – The pathophysiology of irritable bowel syndrome (IBS) was the focus of a presentation given by Dr. Anthony J. Lembo at the 2nd annual Digestive Diseases meeting in Philadelphia on...
WASHINGTON – Performed when recommended, cholecystecomy significantly decreases the risk of near-term rehospitalization for acute biliary pancreatitis, results of a retrospective study...
Celiac disease is not uncommon, affecting about 1% of the population in the United States and around the world, but the biggest barrier to patients receiving treatment is practitioners’ failure to...
Patients with Barrett’s esophagus, a condition in which cells lining the esophagus are replaced by the type of cells that normally line the intestine, need to be monitored carefully to prevent the...
Led by new treatments for hepatitis C, there was an “unprecedented $20.2 billion increase in spending” for new medicines in 2014, which was triple the 2013 level, according to a <a...
ROME – Patients with systemic sclerosis have a distinct colonic microbiota, compared with healthy individuals, which could contribute to their immune dysfunction and symptoms, according to a new...
ROME – Patients with systemic sclerosis who have a range of gastointestinal symptoms and severity have higher amounts of pathogenic bacteria than do normal healthy control patients, according to Dr....
WASHINGTON – More intensive treatment with early combined immunosuppression was associated with a longer time to first flare and fewer flares than conventional management during long-term follow-up...
CHICAGO – Both aspirin and higher plasma levels of vitamin D appear to be modestly effective in secondary prevention of colorectal cancer, investigators in a large cohort study and a randomized trial...
WASHINGTON – Black patients with inflammatory bowel disease were significantly more likely to have at least one extraintestinal manifestation of the disease than were white patients, particularly...
